ISN Journal summaries on corticosteroid treatment in IgAN and the impact of CKD on life participation
Kidney International® A secondary analysis of the TESTING trial predicted individual patient response to corticosteroid treatment in IgA nephropathy This study addressed how to better target corticosteroid treatment in IgA nephropathy, (IgAN) where benefits must be weighed against important side effects. Using a secondary analysis of the TESTING trial, the authors developed a model to predict each patient’s likely response to...